İsrail - İbranice - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ

İsrail - İbranice - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ

İsrail - İbranice - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ

İsrail - İbranice - Ministry of Health

הייר אקספרס בעמ - ריכוך השיער

İsrail - İbranice - Ministry of Health

כמיפל בעמ - חפיפת שיער

İsrail - İbranice - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.

İsrail - İbranice - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

İsrail - İbranice - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methylprednisolone acetate - תרחיף להזרקה - methylprednisolone acetate 40 mg/ml - methylprednisolone - methylprednisolone - for the treatment of conditions responsive to steroid injection therapy.

İsrail - İbranice - Ministry of Health

eli lilly israel ltd, israel - ixekizumab - תמיסה להזרקה - ixekizumab 80 mg / 1 ml - ixekizumab

İsrail - İbranice - Ministry of Health

novartis israel ltd - tisagenlecleucel - tisagenlecleucel